Top Markets
#1 Akedo Akedo +63.33%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.58%
#4 Cross Cross +34.01%
#5 Black Phoenix Black Phoenix +33.94%
#6 Cap Cap +32.66%
#7 Velvet Velvet +25.73%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.06%
#9 Ravencoin Ravencoin +13.84%
#10 DoubleZero DoubleZero +13.55%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rank in Stocks #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Share Price
$0.02243487
Last synced: 2025-06-04
Market Cap
$650.09K
Change (1 day)
0.39%
Change (1 year)
0.00%
Country
SE
Trade Lipidor AB (publ) (LIPI)

Category

Healthcare
EPS for Lipidor AB (publ) (LIPI)
EPS as of December 2024 TTM: $-0.01
According to Lipidor AB (publ) latest financial reports and stock price the company's current EPS (TTM) is $-0.01. At the end of 2023 the company had a EPS of $-0.04 a decrease compared to its 2022 EPS that were of $-0.14.
EPS history for Lipidor AB (publ) from 2016 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 -92.68%
2024 0.00 -92.68%
2023 $-0.04 -70.93%
2022 $-0.14 66.50%
2021 $-0.08 2.38%
2020 $-0.08 9.75%
2019 $-0.07 54.89%
2018 $-0.05 125.96%
2017 $-0.02 -29.97%
2016 $-0.03 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -328,121.98%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -95,154.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -39,110.99%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -224,154.95%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -13,946.15%
US